• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·4198.TWO
Share

S&S Healthcare Holding Ltd. Stocks

NT$ 48.6Last Updated 20.10.2026

Issuer Rating

2/7
Performance

Poor

Risk

Considerable

Recommendation

Sell

Market Cap

NT$ 34.35M

NT$ 48.6
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

S&S Healthcare Holding Ltd. is dedicated to the research, manufacturing, and global commercialization of medical imaging equipment. The company's operations extend across international markets, including significant presences in Taiwan, the United States, and Switzerland. Its product portfolio encompasses advanced digital diagnostic X-ray systems, alongside the engineering and production of devices for bone densitometry and body composition assessment. Established in 1988, S&S Healthcare maintains its headquarters in Taipei, Taiwan. The firm adopted its current name in August 2020, having previously operated as Swissray Global Healthcare Holding Ltd.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 09:54

Revolut has obtained a crypto license in Gibraltar. Why does this neobank need this jurisdiction?

20.10.2026 09:00

Analysts have expressed doubts about demand for the new iPhones. KeyBanc expects Apple's stock to fall 27%.

20.10.2026 08:00

U.S. defense companies fell 16%. Why is the market worried about a Democratic victory in the election?

20.10.2026 04:34

Anthropic is seeking an additional $45 billion in funding. The deal could support its partner Nvidia's IPO

20.10.2026 01:27

A Breather After the Plunge: Nasdaq Rebounded 1.2% as Demand for AI Stocks Returned

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026